Subacute combined degeneration of the spinal cord in a patient with nitrous oxide use and autoimmune atrophic gastritis

BMJ Case Rep. 2023 Nov 30;16(11):e254727. doi: 10.1136/bcr-2023-254727.

Abstract

Nitrous oxide is among the most common drugs used by adolescents and young adults, and its neuropsychiatric sequelae are severe but reversible with timely treatment. The causal mechanism relates to impaired metabolism of vitamin B12, which is necessary for the development and maintenance of the myelin sheath. Individuals most susceptible to neuropsychiatric manifestations are those with a secondary cause of vitamin B12 deficiency, including nutritional deficiency and impaired absorption, or an alternative cause of impaired metaboclism. We describe the case of a man in his thirties who developed subacute combined degeneration of the spinal cord and polyneuropathy in the setting of recreational nitrous oxide use and autoimmune atrophic gastritis. Our case highlights clinical pearls for diagnosis and treatment, differential diagnosis, common concomitant aetiologies and the importance of screening for substance use disorder and psychiatric comorbidities.

Keywords: Neurology; Neuromuscular disease; Psychiatry (drugs and medicines); Spinal cord.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Atrophy / pathology
  • Gastritis* / chemically induced
  • Gastritis* / diagnosis
  • Gastritis* / drug therapy
  • Gastritis, Atrophic* / complications
  • Humans
  • Male
  • Nitrous Oxide / adverse effects
  • Spinal Cord / diagnostic imaging
  • Spinal Cord / pathology
  • Subacute Combined Degeneration* / drug therapy
  • Subacute Combined Degeneration* / etiology
  • Vitamin B 12 / metabolism
  • Vitamin B 12 Deficiency* / chemically induced
  • Vitamin B 12 Deficiency* / complications
  • Vitamin B 12 Deficiency* / diagnosis

Substances

  • Nitrous Oxide
  • Vitamin B 12